Comparing minimally invasive and open surgery for pancreatic cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the safety and efficiency of minimally invasive pancreaticoduodenectomy (including laparoscopic and robotic techniques) with traditional open pancreaticoduodenectomy for patients with pancreatic cancer. It is a prospective randomized trial where eligible patients are assigned to either surgical approach before their operation. Key outcomes evaluated include hospital stay, blood loss, surgical radicality, operation duration, complication rates, and long-term survival metrics such as disease-free and overall survival.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age: \>18yr, \<75yr
* Patients with pancreatic cancer or non-pancreatic cancers (biliary duct cancer or ampullary cancer) who underwent pancreatoduodenectomy
* Preoperative imaging assessment is resectable or borderline resectable

Exclusion Criteria:

* Benign tumors of the head of pancreas
* Enhanced CT diagnosis revealed that the excess of SMV was more than 180 degrees, or distant metastasis.
* conversion to laparotomy because of intraoperative difficulty

Where it's running

• Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Menghua Dai, MD
• Email: DaiMH@pumch.cn
• Phone: +861069152600

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Laryngopharyngeal injuries after breathing tube placement during general anesthesia

  This project sees how often and why people who had a breathing tube during general anesthesia developed hoarseness or other throat problems after non-ear–nose–throat surgery.

  Recruiting Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT07359586

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

• Dual-target CAR-T therapy targeting mesothelin and CLDN18.2 for advanced pancreatic cancer

  This treatment will try sequential CAR‑T cell infusions that target mesothelin and CLDN18.2 in people with unresectable or metastatic pancreatic adenocarcinoma who have received prior systemic therapy.

  Recruiting Phase 1/2 Essen Biotech · Beijing, Beijing Municipality · NCT07066995

• Vanguard: a new blood test approach to screen for multiple cancers

  This study will test two different blood-based multi-cancer detection tests in adults 45–75 without cancer to see if they find cancers earlier than usual care.

  Recruiting at 46 sites National Cancer Institute (NCI) · Pleasanton, California and 45 other locations · NCT06995898

• Lanreotide versus placebo before surgery to prevent a pancreatic fistula

  This trial will see if giving lanreotide before a planned distal pancreatectomy lowers the risk of a pancreatic fistula in adults with pancreatic cancer or a suspicious pancreatic lesion.

  Recruiting at 18 sites Phase 3 SWOG Cancer Research Network · Birmingham, Alabama and 117 other locations · NCT06807437

• Testing XNW28012 in patients with advanced solid tumors who have not responded to standard treatments

  This study is testing a new treatment called XNW28012 in patients with advanced solid tumors who haven't had success with regular cancer therapies to see if it can help them.

  Recruiting at 24 sites Phase 1/2 Evopoint Biosciences Inc. · Hefei, Anhui and 23 other locations · NCT06799637

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.